New studies reportedly suggest lasting immunity to COVID-19 even in mild cases


Experts are voicing optimism that the body provides lasting COVID-19 immunity in those who have recovered from even a mild case following a series of new studies.
Scientists have recently been seeing "encouraging signs of strong, lasting immunity" to COVID-19, including in those who only had mild symptoms of the coronavirus, as antibodies that fight against the virus, and B cells and T cells that recognize it, "appear to persist months after infections have resolved," The New York Times reports.
"This is exactly what you would hope for," University of Washington immunologist Marion Pepper, who authored one of the recent studies, told the Times. "All the pieces are there to have a totally protective immune response."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Especially encouraging, the Times explains, is evidence of immunity in patients who just had mild symptoms, which suggests, as University of California immunologist Smita Iyer explained, that "you can still get durable immunity without suffering the consequences of infection." Emory University immunologist Eun-Hyung Lee also told the Times, "Yes, you do develop immunity to this virus, and good immunity to this virus. That's the message we want to get out there."
At the same time, the Times notes that it's still not clear how long the immune responses might last, and the recent studies "do not demonstrate protection in action." Read more at The New York Times.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
What to know before turning to AI for financial advice
the explainer It can help you crunch the numbers — but it might also pocket your data
-
Book reviews: 'The Headache: The Science of a Most Confounding Affliction—and a Search for Relief' and 'Tonight in Jungleland: The Making of Born to Run'
Feature The search for a headache cure and revisiting Springsteen's 'Born to Run' album on its 50th anniversary
-
Keith McNally' 6 favorite books that have ambitious characters
Feature The London-born restaurateur recommends works by Leo Tolstoy, John le Carré, and more
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC